[1]
|
Martinez, M., Santamarina, J., Pavesi, A., et al. (2021) Glycemic Variability and Cardiovascular Disease in Patients with Type 2 Diabetes. BMJ Open Diabetes Research & Care, 9, e002032. https://doi.org/10.1136/bmjdrc-2020-002032
|
[2]
|
Shi, H., Gw, Y.S., Wang, H.M., et al. (2021) Fasting Blood Glucose and Risks of Stroke: A Dose-Response Meta-Analysis. Clinical Nutrition, 40, 3296-3304. https://doi.org/10.1016/j.clnu.2020.10.054
|
[3]
|
Wang, Y., Zhu, L., Tan, X., et al. (2022) Higher Levels of Periph-eral Blood Glucose in the Actue Stage of Stroke Increase the Risk of Post-Stroke Depression: A Sysematic Review and Meta-Analysis. Neuroscience & Biobehavioral Reviews, 142, Article ID: 104829. https://doi.org/10.1016/j.neubiorev.2022.104829
|
[4]
|
杨倩, 刘祚燕, 王凤英. 老年老年糖尿病合并脑卒中患者血糖水平与神经功能恢复的相关性分析[J]. 老年医学与保健, 2021, 27(2): 405-408
|
[5]
|
Emerging Risk Factors Collaboration, Sarwar, N., Gao, P., et al. (2010) Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: A Collaborative Meta-Analysis of 102 Prospective Studies. The Lancet, 375, 2215-2222. https://doi.org/10.1016/S0140-6736(10)60484-9
|
[6]
|
Georgakis, M.K., Harshfied, E.L., Malik, R., Franceschini, N., Langenberg, C., Wareham, N.J., Markus, H.S. and Dichgans, M. (2021) Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study. Neurology, 96, e1732-e1742.
|
[7]
|
Palaiodimou, L., Liou-tas, V.A., Lambadiar, V., et al. (2021) Glycemicvariability of Acute Stroke Patients and Clinical Outcomes: A Continu-ous Glucose Monitoring Study. Therapeutic Advances in Neurological Disorders, 14, 1-13.
https://doi.org/10.1177/17562864211045876
|
[8]
|
朱婧, 罗彩凤, 倪益益, 等. 2型糖尿病病人并发缺血性脑卒中急性期血糖波动趋势及影响因素分析[J]. 安徽医药, 2019, 23(12): 2395-2399.
|
[9]
|
Bril, F., Mcphaul, M.J., Caulfield, M.P., et al. (2019) Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a Multiethnic Cohort of Patients with Type 2 Diabetes Mellitus. Journal of Investigative Medicine, 67, 303-311.
https://doi.org/10.1136/jim-2018-000864
|
[10]
|
黄金鑫, 吕肖锋, 李娟, 等. 2型糖尿病合并急性脑梗死患者入院早期血糖波动及其临床意义[J]. 中国糖尿病杂志, 2014, 22(3): 200-203.
|
[11]
|
Kim, Y.S., Kim, C., Jung, K.H., et al. (2017) Range of Glucose as a Glycemic Variability and 3-Month Outcome Indiabet Patients with Actue Ischemic Stroke. PLOS ONE, 12, e0183894. https://doi.org/10.1371/journal.pone.0183894
|
[12]
|
Huang, J.X., Zhang, X.G., Li, J., et al. (2014) Impact of Glucose Fluctuation on Acute Cerebral Infarction in Type 2 Diabetes. Canadian Journal of Neurological Sciences, 41, 486-492. https://doi.org/10.1017/S0317167100018539
|
[13]
|
Saposnik, G., Fang, J., Kapral, M.K., Tu, J.V., Mamdani, M., Austin, P., et al. (2012) The iScore Predicts Effectiveness of Thrombolytic Ther-apy for Acute Ischemic Stroke. Stroke, 43, 1315-1322.
https://doi.org/10.1161/STROKEAHA.111.646265
|
[14]
|
Heldner, M.R., Zubler, C., Mattle, H.P., Schroth, G., Weck, A., Mono, M.L., et al. (2013) National Institutes of Health Stroke Scale Score and Vessel Occlusion in 2152 Pa-tients with Acute Ischemic Stroke. Stroke, 44, 1153-1157.
https://doi.org/10.1161/STROKEAHA.111.000604
|
[15]
|
Jia, Q., Zhao, X., Wang, C., Wang, Y., Yan, Y., Li, H., et al. (2011) Diabetes and Poor Outcomes within 6 Months after Acute Ischemic Stroke: The China National Stroke Regis-try. Stroke, 42, 2758-2762.
https://doi.org/10.1161/STROKEAHA.111.621649
|
[16]
|
Ormstad, H., Aass, H.C., Amthor, K.F., Lund-Sørensen, N. and Sandvik, L. (2012) Serum Levels of Cytokines, Glucose, and Hemoglobin as Possible Predictors of Poststroke Depression, and Association with Poststroke Fatigue. International Journal of Neuroscience, 122, 682-690. https://doi.org/10.3109/00207454.2012.709892
|
[17]
|
Kruyt, N.D., van Westerloo, D.J. and DeVries, J.H. (2012) Stress-Induced Hyperglycemia in Healthy Bungee Jumpers without Diabetes Due to Decreased Pancreatic β-Cell Func-tion and Increased Insulin Resistance. Diabetes Technology & Therapeutics, 14, 311-314. https://doi.org/10.1089/dia.2011.0171
|
[18]
|
Yu, K.H., Hong, K.S., Lee, B.C., Oh, M.S., Cho, Y.J., Koo, J.S., et al. (2011) Comparison of 90-Day Case-Fatality after Ischemic Stroke between Two Different Stroke Outcome Registries Using Propensity Score Matching Analysis. Acta Neurologica Scandinavica, 123, 325-331. https://doi.org/10.1111/j.1600-0404.2010.01406.x
|
[19]
|
Chen, R.L., Balami, J.S., Esiri, M.M., Chen, L.K. and Buchan, A.M. (2010) Ischemic Stroke in the Elderly: An Overview of Evidence. Nature Reviews Neurology, 6, 256-265. https://doi.org/10.1038/nrneurol.2010.36
|
[20]
|
Shimoyama, T., Kimura, K., Uemura, J., Saji, N. and Shibazaki, K. (2014) Elevated Glucose Level Adversely Affects Infarct Volume Growth and Neurological Deterioration in Non-Diabetic Stroke Patients, But Not Diabetic Stroke Patients. European Journal of Neurology, 21, 402-410. https://doi.org/10.1111/ene.12280
|
[21]
|
Bellolio, M.F., Gilmore, R.M. and Ganti, L. (2014) Insulin for Glycaemic Control in Acute Ischaemic Stroke. Cochrane Database of Systematic Reviews, 1, CD005346. https://doi.org/10.1002/14651858.CD005346.pub4
|
[22]
|
Bahader, G.A., Nash, K.M., Almarghalani, D.A., et al. (2021) Type-I Diabetes Aggravates Post-Hemorrhagic Stroke Cognitive Impairment by Augmenting Oxidative Stress and Neuroinflammation in Mice. Neurochemistry International, 149, Article ID: 105151. https://doi.org/10.1016/j.neuint.2021.105151
|
[23]
|
Orasanu, G. and Plutzky, J. (2009) The Continuum of Diabetic Vascular Disease: From Macro- to Micro. Journal of the American College of Cardiology, 53, S35-S42.
|
[24]
|
Zhou, J.W., Wu, J.H., Zhang, J.T., et al. (2015) Association of Stroke Clinical Outcomes with Coexistence of Hyperglycemia and Biomarkers of Inflammation. Journal of Stroke and Cerebrovascular Diseases, 24, 1250-1255.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.01.028
|
[25]
|
Cai, R., Han, J., Sun, J., et al. (2016) Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Pa-tients. Frontiers in Aging Neuroscience, 8, Article 179.
https://doi.org/10.3389/fnagi.2016.00179
|
[26]
|
Polidori, M.C., Mecocci, P., Stahl, W., et al. (2000) Plasma Levels of Lipophilic Antioxidants in Very Old Patients with Type 2 Diabetes. Diabetes/Metabolism Research and Reviews, 16, 15-19.
https://doi.org/10.1002/(SICI)1520-7560(200001/02)16:1<15::AID-DMRR71>3.3.CO;2-2
|
[27]
|
Ronchi, D., Palmer, K., Pioggiosi, P., et al. (2007) The Combined Effect of Age, Education, and Stroke on Dementia and Cognitive Impairment No Dementia in the Elderly. Dementia and Geriatric Cognitive Disorders, 24, 266-273.
https://doi.org/10.1159/000107102
|
[28]
|
Mackness, B., Hunt, R., Durrington, P.N. and Mackness, M.I. (1997) In-creased Immunolocalization of Paraoxonase, Clusterin, and Apolipoprotein A-I in the Human Artery Wall with the Pro-gression of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 1233-1238. https://doi.org/10.1161/01.ATV.17.7.1233
|
[29]
|
Ahmad, W. (2013) Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes. Molecular Neurobiology, 47, 399-424. https://doi.org/10.1007/s12035-012-8352-z
|
[30]
|
Albai, O., Frandes, M., Timar, R., Roman, D. and Timar, B. (2019) Risk Factors for Developing Dementia in Type 2 Diabetes Mellitus Patients with Mild Cognitive Impairment. Neuropsy-chiatric Disease and Treatment, 15, 167-175.
|